Learning to read again Study participant Sheila Irvine, a patient at Moorfields Eye Hospital, training with the PRIMA device. (Courtesy: Moorfields Eye Hospital) A tiny wireless implant inserted under ...

Doctors at Duke Health are using a cell-based implant to slow down the progression of MacTel, a rare retinal disease that ...

Diabetes is the leading cause of vision loss in people between 18 and 64 years old, according to the American Diabetes Association — and the best way to prevent this is to control blood sugar levels.

Doris is an 86-year-old woman who has been experiencing blurred vision in the left eye for the past month. B. Assessment and diagnosis only; I refer for treatment. C. Assessment only; I refer for ...

The new study, undertaken by researchers at Oregon Health & Science University and published by Jama Ophthalmology, suggests that GLP-1 drugs such as Ozempic and Monjaro can reduce the risk of ...

Age-related macular degeneration (AMD) is a common eye condition in older adults that can affect central vision. Geographic atrophy is an advanced form of AMD that causes permanent vision changes.

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for type 2 diabetes and weight loss. Medications such as Ozempic, Wegovy, Mounjaro ...

Patients who were prescribed Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or other GLP-1 receptor agonist medications to treat type 2 diabetes or for weight loss may be at risk ...

Eye care should not begin only when vision becomes blurry. The eyes change through childhood, school years, adulthood, and older age, and each stage brings different risks. Children need healthy ...

Neha Pathak, MD, FACP, DipABLM: Welcome to the WebMD Health Discovered Podcast. I'm Dr Neha Pathak, WebMD's Chief Physician Editor for Health and Lifestyle Medicine. Okay, right now millions of people ...

New research suggests that weight-loss drugs can help prevent vision loss as patients age, but there’s a major caveat. GLP-1 weight-loss drugs linked to reduced risk of age-related macular ...